Innovative wearable technology will detect breathing problems in infants

An innovative wearable sensor to monitor new-born babies in poor areas is being developed by Anglia Ruskin University, in collaboration with experts in Jordan.

Academics will create wearable technology to accurately measure the respiratory rate in new-born babies, specifically for areas where access to healthcare is poor.

Researchers were alerted to the scale of the issue through their work in the Zaatri refugee camp in Jordan, where they saw the effect that limited access to respiratory monitoring impacted access to appropriate healthcare.

According to the United Nations High Commissioner for Refugees, 60% of neo-natal deaths in the camp were associated with preterm birth and its associated complication of respiratory stress syndrome.

This international collaborative project will develop a wearable sensor that makes use of wireless communication to provide continuous remote monitoring of an infant's breathing. This in turn will support faster, more accurate identification of health conditions in new-borns.

Inkjet-printing technology will create stretchable and biocompatible sensors for the monitor, and the project team will work closely with industry to ensure the designs conform to medical standards and can be easily commercialised.

Professor Dingchang Zheng, of Anglia Ruskin University, said: "The first week of life is crucial for new-born babies, and in low income areas, access to appropriate healthcare is often limited. If a baby develops a problem, it can sometimes be too late before the issue is diagnosed.

"As a result, there is an increasing need for remote, low-cost, reliable, and comfortable respiratory rate sensors that provide physicians with accurate readings and to assess the health condition of new-borns.

"We are developing a sensor which will be made of flexible and biocompatible materials with an attachment mechanism that avoids skin infection caused by traditional adhesive electrodes.

"We're delighted to be working with our partners in Jordan to create this vital piece of technology. We believe it will have a real tangible benefit which can save the lives of vulnerable babies."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New single-chain mRNA vaccines offer enhanced immunity and protection against mpox